243 related articles for article (PubMed ID: 35138562)
1. Characterization of vitamin D metabolism in active acromegaly in the setting of bolus (150,000 IU) cholecalciferol treatment.
Povaliaeva AA; Bogdanov VP; Zhukov AY; Pigarova EA; Dzeranova LK; Rozhinskaya LY; Mel'nichenko GA; Mokrysheva NG
Endocrine; 2022 May; 76(2):407-418. PubMed ID: 35138562
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Vitamin D Metabolism in Patients with Cushing's Disease in Response to 150,000 IU Cholecalciferol Treatment.
Povaliaeva A; Bogdanov V; Pigarova E; Zhukov A; Dzeranova L; Belaya Z; Rozhinskaya L; Mel'nichenko G; Mokrysheva N
Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959880
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. [Vitamin D metabolite and calcium phosphorus metabolism in in patients with primary hyperparathyroidism on the background of bolus therapy with colecalciferol].
Maganeva IS; Pigarova EA; Shulpekova NV; Dzeranova LK; Eremkina AK; Miliutina AP; Povaliaeva AA; Zhukov AY; Bogdanov VP; Rozhinskaya LY; Mokrysheva NG
Probl Endokrinol (Mosk); 2021 Dec; 67(6):68-79. PubMed ID: 35018763
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Vitamin D Metabolism in Patients with Type 1 Diabetes Mellitus in the Setting of Cholecalciferol Treatment.
Povaliaeva A; Pigarova E; Zhukov A; Bogdanov V; Dzeranova L; Mel'nikova O; Pekareva E; Malysheva N; Ioutsi V; Nikankina L; Rozhinskaya L
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33352890
[TBL] [Abstract][Full Text] [Related]
6. The Effect of a Single High Dose of Vitamin D on Serum Levels of Its Metabolites in the Elderly.
Leszczyńska D; Szatko A; Kowalski K; Raczkiewicz D; Ostrowska M; Misiorowski W; Zgliczyński W; Glinicki P
Front Biosci (Landmark Ed); 2022 Oct; 27(10):289. PubMed ID: 36336861
[TBL] [Abstract][Full Text] [Related]
7. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
8. Dynamic Evaluation of Vitamin D Metabolism in Post-Bariatric Patients.
Povaliaeva A; Zhukov A; Tomilova A; Bondarenko A; Ovcharov M; Antsupova M; Ioutsi V; Shestakova E; Shestakova M; Pigarova E; Rozhinskaya L; Mokrysheva N
J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202014
[TBL] [Abstract][Full Text] [Related]
9. Parameters of Vitamin D Metabolism in Patients with Hypoparathyroidism.
Zhukov A; Povaliaeva A; Abilov Z; Kovaleva E; Usoltseva L; Eremkina A; Ioutsi V; Dzeranova L; Pigarova E; Rozhinskaya L; Mokrysheva N
Metabolites; 2022 Dec; 12(12):. PubMed ID: 36557317
[TBL] [Abstract][Full Text] [Related]
10. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: A randomized controlled trial in older adults.
Vaes AMM; Tieland M; de Regt MF; Wittwer J; van Loon LJC; de Groot LCPGM
Clin Nutr; 2018 Jun; 37(3):808-814. PubMed ID: 28433267
[TBL] [Abstract][Full Text] [Related]
11. Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD.
Stubbs JR; Zhang S; Friedman PA; Nolin TD
Clin J Am Soc Nephrol; 2014 Nov; 9(11):1965-73. PubMed ID: 25183657
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.
Giusti A; Barone A; Pioli G; Girasole G; Razzano M; Pizzonia M; Pedrazzoni M; Palummeri E; Bianchi G
J Am Geriatr Soc; 2010 Aug; 58(8):1489-95. PubMed ID: 20646099
[TBL] [Abstract][Full Text] [Related]
13. [Cholecalciferol supplementation improves secondary hyperparathyroidism control in hemodialysis patients].
Massimetti C; Bellasi A; Feriozzi S
G Ital Nefrol; 2020 Jun; 37(3):. PubMed ID: 32530156
[No Abstract] [Full Text] [Related]
14. Serum 24,25-dihydroxyvitamin D
Graeff-Armas LA; Kaufmann M; Lyden E; Jones G
Clin Nutr; 2018 Jun; 37(3):1041-1045. PubMed ID: 28506446
[TBL] [Abstract][Full Text] [Related]
15. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
Leventis P; Kiely PD
Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
[TBL] [Abstract][Full Text] [Related]
16. Impaired Vitamin D Metabolism in Hospitalized COVID-19 Patients.
Povaliaeva A; Bogdanov V; Pigarova E; Dzeranova L; Katamadze N; Malysheva N; Ioutsi V; Nikankina L; Rozhinskaya L; Mokrysheva N
Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 35893730
[TBL] [Abstract][Full Text] [Related]
17. EXPERIMENTAL CHOLECALCIFEROL SUPPLEMENTATION IN A HERD OF MANAGED ASIAN ELEPHANTS (
Childs-Sanford SE; Makowski AJ; Hilliard RL; Wakshlag JJ
J Zoo Wildl Med; 2023 Jul; 54(2):219-230. PubMed ID: 37428684
[TBL] [Abstract][Full Text] [Related]
18. Impact of a single oral dose of 100,000 IU vitamin D3 on profiles of serum 25(OH)D3 and its metabolites 24,25(OH)2D3, 3-epi-25(OH)D3, and 1,25(OH)2D3 in adults with vitamin D insufficiency.
Saleh L; Tang J; Gawinecka J; Boesch L; Fraser WD; von Eckardstein A; Nowak A
Clin Chem Lab Med; 2017 Oct; 55(12):1912-1921. PubMed ID: 28328526
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D Metabolite Profile in Cholecalciferol- or Calcitriol-Supplemented Healthy and Mammary Gland Tumor-Bearing Mice.
Anisiewicz A; Kowalski K; Banach J; Łabędź N; Stachowicz-Suhs M; Piotrowska A; Milczarek M; Kłopotowska D; Dzięgiel P; Wietrzyk J
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33172201
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D metabolism in living kidney donors before and after organ donation.
Enko D; Meinitzer A; Zelzer S; Herrmann M; Artinger K; Rosenkranz AR; Zitta S
Clin Chem Lab Med; 2022 Jul; 60(8):1218-1224. PubMed ID: 35514251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
